{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,25]],"date-time":"2026-02-25T13:10:36Z","timestamp":1772025036473,"version":"3.50.1"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2020,5,23]],"date-time":"2020-05-23T00:00:00Z","timestamp":1590192000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2020,5,23]],"date-time":"2020-05-23T00:00:00Z","timestamp":1590192000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur Spine J"],"published-print":{"date-parts":[[2020,8]]},"DOI":"10.1007\/s00586-020-06466-9","type":"journal-article","created":{"date-parts":[[2020,5,23]],"date-time":"2020-05-23T06:02:52Z","timestamp":1590213772000},"page":"1813-1822","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["RETRACTED ARTICLE: Patients with ankylosing spondylitis treatment by golimumab: a systematic review and meta-analysis"],"prefix":"10.1007","volume":"29","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2479-2589","authenticated-orcid":false,"given":"Jami","family":"Sayed Abdulla","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7796-8798","authenticated-orcid":false,"given":"Jiandang","family":"Shi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8131-4161","authenticated-orcid":false,"given":"Brotendu Shekhar","family":"Roy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6042-5228","authenticated-orcid":false,"given":"Zhou","family":"Zhanwen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3050-4803","authenticated-orcid":false,"given":"Changhao","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,5,23]]},"reference":[{"issue":"9","key":"6466_CR1","doi-asserted-by":"publisher","first-page":"1654","DOI":"10.1093\/rheumatology\/keu132","volume":"53","author":"C Bao","year":"2014","unstructured":"Bao C, Huang F, Khan MA, Fei K, Wu Z, Han C, Hsia EC (2014) Safety and efficacy of golimumab in Chinese patients with active ankylosing spondylitis: 1-year results of a multicentre, randomized, double-blind, placebo-controlled phase III trial. Rheumatology (Oxford, England) 53(9):1654\u20131663. https:\/\/doi.org\/10.1093\/rheumatology\/keu132","journal-title":"Rheumatology (Oxford, England)"},{"issue":"5","key":"6466_CR2","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1136\/ard.2011.154799","volume":"71","author":"J Braun","year":"2012","unstructured":"Braun J, Deodhar A, Inman RD, van der Heijde D, Mack M, Xu S, Hsu B (2012) Golimumab administered subcutaneously every 4 weeks in ankylosing spondylitis: 104-week results of the GO-RAISE study. Ann Rheum Dis 71(5):661\u2013667. https:\/\/doi.org\/10.1136\/ard.2011.154799","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"6466_CR3","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1136\/annrheumdis-2014-205862","volume":"74","author":"A Deodhar","year":"2015","unstructured":"Deodhar A, Braun J, Inman RD, van der Heijde D, Zhou Y, Xu S, Han C, Hsu B (2015) Golimumab administered subcutaneously every 4 weeks in ankylosing spondylitis: 5-year results of the GO-RAISE study. Ann Rheum Dis 74(4):757\u2013761. https:\/\/doi.org\/10.1136\/annrheumdis-2014-205862","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"6466_CR4","doi-asserted-by":"publisher","first-page":"341","DOI":"10.3899\/jrheum.170487","volume":"45","author":"A Deodhar","year":"2018","unstructured":"Deodhar A, Reveille JD, Harrison DD, Kim L, Lo KH, Leu JH, Hsia EC (2018) Safety and efficacy of golimumab administered intravenously in adults with ankylosing spondylitis: results through week 28 of the GO-ALIVE Study. J Rheumatol 45(3):341\u2013348. https:\/\/doi.org\/10.3899\/jrheum.170487","journal-title":"J Rheumatol"},{"issue":"3","key":"6466_CR5","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1007\/s40259-017-0217-6","volume":"31","author":"JE Frampton","year":"2017","unstructured":"Frampton JE (2017) Golimumab: a review in inflammatory arthritis. BioDrugs: Clin Immunother Biopharm Gene Therapy 31(3):263\u2013274. https:\/\/doi.org\/10.1007\/s40259-017-0217-6","journal-title":"BioDrugs: Clin Immunother Biopharm Gene Therapy"},{"issue":"11","key":"6466_CR6","doi-asserted-by":"publisher","first-page":"3402","DOI":"10.1002\/art.23969","volume":"58","author":"RD Inman","year":"2008","unstructured":"Inman RD, Davis JC Jr, Heijde D, Diekman L, Sieper J, Kim SI, Mack M, Han J, Visvanathan S, Xu Z, Hsu B, Beutler A, Braun J (2008) Efficacy and safety of golimumab in patients with ankylosing spondylitis: results of a randomized, double-blind, placebo-controlled, phase III trial. Arthritis Rheum 58(11):3402\u20133412. https:\/\/doi.org\/10.1002\/art.23969","journal-title":"Arthritis Rheum"},{"issue":"3","key":"6466_CR7","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1136\/annrheumdis-2013-204195","volume":"74","author":"J Kay","year":"2015","unstructured":"Kay J, Fleischmann R, Keystone E, Hsia EC, Hsu B, Mack M, Goldstein N, Braun J, Kavanaugh A (2015) Golimumab 3-year safety update: an analysis of pooled data from the long-term extensions of randomised, double-blind, placebo-controlled trials conducted in patients with rheumatoid arthritis, psoriatic arthritis or ankylosing spondylitis. Ann Rheum Dis 74(3):538\u2013546. https:\/\/doi.org\/10.1136\/annrheumdis-2013-204195","journal-title":"Ann Rheum Dis"},{"issue":"11","key":"6466_CR8","doi-asserted-by":"publisher","first-page":"2121","DOI":"10.1007\/s00296-018-4124-z","volume":"38","author":"K Kruger","year":"2018","unstructured":"Kruger K, von Hinuber U, Meier F, Tian H, Bohm K, Jugl SM, Borchert K, Meise D, Konig C, Braun S (2018) Ankylosing spondylitis causes high burden to patients and the healthcare system: results from a German claims database analysis. Rheumatol Int 38(11):2121\u20132131. https:\/\/doi.org\/10.1007\/s00296-018-4124-z","journal-title":"Rheumatol Int"},{"issue":"12","key":"6466_CR9","doi-asserted-by":"publisher","first-page":"935","DOI":"10.3760\/cma.j.issn.0578-1426.2017.12.009","volume":"56","author":"H Ma","year":"2017","unstructured":"Ma H, Sun F, Zhang YM, Zhang H, Zhu J, Deng XH, Zhang JL, Huang F (2017) The safety and efficacy of golimumab in treatment of 25 patients with active ankylosing spondylitis. Zhonghua nei ke za zhi 56(12):935\u2013939. https:\/\/doi.org\/10.3760\/cma.j.issn.0578-1426.2017.12.009","journal-title":"Zhonghua nei ke za zhi"},{"issue":"5","key":"6466_CR10","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1586\/14737167.2015.1044514","volume":"15","author":"J Martinez-Cutillas","year":"2015","unstructured":"Martinez-Cutillas J, Alerany-Pardo C, Borras-Blasco J, Broto-Sumalla A, Burgos-SanJose A, Climent-Bolta C, Escudero-Vilaplana V, Fernandez-Fuente MA, Ferrit-Martin M, Gomez-Germa P, Martinez-Sesmero JM, Mayorga-Perez J, Menchen-Viso B, Merino-Alonso J, Polache-Vengud J, Sanchez-Guerrero A (2015) The use of adalimumab, etanercept, golimumab and infliximab in rheumatic pathologies: variation between label dosage and real-world use. Exp Rev Pharmacoeconomics Outcomes Res 15(5):851\u2013858. https:\/\/doi.org\/10.1586\/14737167.2015.1044514","journal-title":"Exp Rev Pharmacoeconomics Outcomes Res"},{"key":"6466_CR11","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD005468.pub2","author":"LJ Maxwell","year":"2015","unstructured":"Maxwell LJ, Zochling J, Boonen A, Singh JA, Veras MM, Tanjong Ghogomu E, Benkhalti Jandu M, Tugwell P, Wells GA (2015) TNF-alpha inhibitors for ankylosing spondylitis. Cochrane Database Syst Rev. https:\/\/doi.org\/10.1002\/14651858.CD005468.pub2","journal-title":"Cochrane Database Syst Rev"},{"issue":"1","key":"6466_CR12","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1136\/annrheumdis-2017-211544","volume":"77","author":"C Molnar","year":"2018","unstructured":"Molnar C, Scherer A, Baraliakos X, de Hooge M, Micheroli R, Exer P, Kissling RO, Tamborrini G, Wildi LM, Nissen MJ, Zufferey P, Bernhard J, Weber U, Landewe RBM, van der Heijde D, Ciurea A (2018) TNF blockers inhibit spinal radiographic progression in ankylosing spondylitis by reducing disease activity: results from the Swiss Clinical Quality Management cohort. Ann Rheum Dis 77(1):63\u201369. https:\/\/doi.org\/10.1136\/annrheumdis-2017-211544","journal-title":"Ann Rheum Dis"},{"key":"6466_CR13","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.conctc.2018.07.004","volume":"11","author":"MH Rahbar","year":"2018","unstructured":"Rahbar MH, Lee M, Hessabi M, Tahanan A, Brown MA, Learch TJ, Diekman LA, Weisman MH, Reveille JD (2018) Harmonization, data management, and statistical issues related to prospective multicenter studies in Ankylosing spondylitis (AS): Experience from the Prospective Study Of Ankylosing Spondylitis (PSOAS) cohort. Contemp Clin Trials Commun 11:127\u2013135. https:\/\/doi.org\/10.1016\/j.conctc.2018.07.004","journal-title":"Contemp Clin Trials Commun"},{"issue":"7","key":"6466_CR14","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.1136\/annrheumdis-2014-205253","volume":"74","author":"C Stolwijk","year":"2015","unstructured":"Stolwijk C, Essers I, van Tubergen A, Boonen A, Bazelier MT, De Bruin ML, de Vries F (2015) The epidemiology of extra-articular manifestations in ankylosing spondylitis: a population-based matched cohort study. Ann Rheum Dis 74(7):1373\u20131378. https:\/\/doi.org\/10.1136\/annrheumdis-2014-205253","journal-title":"Ann Rheum Dis"},{"issue":"6","key":"6466_CR15","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1093\/rheumatology\/ket469","volume":"53","author":"LS Tam","year":"2014","unstructured":"Tam LS, Shang Q, Kun EW, Lee KL, Yip ML, Li M, Li TK, Zhu TY, Pui MO, Li EK, Yu CM (2014) The effects of golimumab on subclinical atherosclerosis and arterial stiffness in ankylosing spondylitis-a randomized, placebo-controlled pilot trial. Rheumatology (Oxford, England) 53(6):1065\u20131074. https:\/\/doi.org\/10.1093\/rheumatology\/ket469","journal-title":"Rheumatology (Oxford, England)"},{"issue":"6","key":"6466_CR16","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.3899\/jrheum.131003","volume":"41","author":"D van der Heijde","year":"2014","unstructured":"van der Heijde D, Deodhar A, Braun J, Mack M, Hsu B, Gathany TA, Inman RD, Han C (2014) The effect of golimumab therapy on disease activity and health-related quality of life in patients with ankylosing spondylitis: 2-year results of the GO-RAISE trial. J Rheumatol 41(6):1095\u20131103. https:\/\/doi.org\/10.3899\/jrheum.131003","journal-title":"J Rheumatol"},{"issue":"4","key":"6466_CR17","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1016\/j.jspd.2017.06.001","volume":"6","author":"Y Wang","year":"2018","unstructured":"Wang Y, Zheng GQ, Zhang YG, Song K, Song DY, Zhang XS, Wang Z, Lu N, Mao KY (2018) Proposal of a new treatment-oriented classification system for spinal deformity in ankylosing spondylitis. Spine Deform 6(4):366\u2013372. https:\/\/doi.org\/10.1016\/j.jspd.2017.06.001","journal-title":"Spine Deform"},{"issue":"4","key":"6466_CR18","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1002\/jcph.1348","volume":"59","author":"J Wronski","year":"2019","unstructured":"Wronski J, Fiedor P (2019) The safety profile of tumor necrosis factor inhibitors in ankylosing spondylitis: Are TNF inhibitors safer than we thought? J Clin Pharmacol 59(4):445\u2013462. https:\/\/doi.org\/10.1002\/jcph.1348","journal-title":"J Clin Pharmacol"}],"updated-by":[{"DOI":"10.1007\/s00586-022-07129-7","type":"retraction","label":"Retraction","source":"retraction-watch","updated":{"date-parts":[[2022,2,14]],"date-time":"2022-02-14T00:00:00Z","timestamp":1644796800000},"record-id":"35468"},{"DOI":"10.1007\/s00586-020-06466-9","type":"retraction","label":"Retraction","source":"publisher","updated":{"date-parts":[[2022,2,14]],"date-time":"2022-02-14T00:00:00Z","timestamp":1644796800000}},{"DOI":"10.1007\/s00586-022-07129-7","type":"retraction","label":"Retraction","source":"publisher","updated":{"date-parts":[[2022,2,14]],"date-time":"2022-02-14T00:00:00Z","timestamp":1644796800000}}],"container-title":["European Spine Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00586-020-06466-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00586-020-06466-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00586-020-06466-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,25]],"date-time":"2026-02-25T12:10:00Z","timestamp":1772021400000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00586-020-06466-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5,23]]},"references-count":18,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2020,8]]}},"alternative-id":["6466"],"URL":"https:\/\/doi.org\/10.1007\/s00586-020-06466-9","relation":{},"ISSN":["0940-6719","1432-0932"],"issn-type":[{"value":"0940-6719","type":"print"},{"value":"1432-0932","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,5,23]]},"assertion":[{"value":"5 February 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 February 2020","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 May 2020","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 May 2020","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 February 2022","order":6,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":7,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This article has been retracted. Please see the Retraction Notice for more detail:","order":8,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1007\/s00586-022-07129-7","URL":"https:\/\/doi.org\/10.1007\/s00586-022-07129-7","order":9,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}